Correction to: Anifrolumab in Monogenic Lupus caused by TREX1 Mutation

Affiliations

¹ Division of Rheumatology, and the Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, Institute for Research and Health Care (IRCCS), Ospedale Pediatrico Bambino Gesù, Rome, Italy.
² Pediatric Division, Sant'Eugenio Hospital, ASL Roma 2, Rome, Italy.
³ Division of Rheumatology, and the Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, Institute for Research and Health Care (IRCCS), Ospedale Pediatrico Bambino Gesù, Rome, Italy. antonella.insalaco@opbg.net.

Published Erratum

Patricia Moran-Alvarez et al. J Clin Immunol. 2025.

. 2025 Feb 3;45(1):70.

doi: 10.1007/s10875-025-01864-4.

¹ Division of Rheumatology, and the Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, Institute for Research and Health Care (IRCCS), Ospedale Pediatrico Bambino Gesù, Rome, Italy.
² Pediatric Division, Sant'Eugenio Hospital, ASL Roma 2, Rome, Italy.
³ Division of Rheumatology, and the Unit of Medical Genetics, Laboratory of Cytogenetics and Molecular Genetics, Institute for Research and Health Care (IRCCS), Ospedale Pediatrico Bambino Gesù, Rome, Italy. antonella.insalaco@opbg.net.

No abstract available

Erratum for

Anifrolumab in Monogenic Lupus caused by TREX1 Mutation.
Moran-Alvarez P, Messia V, Matteo V, Soscia F, Prencipe G, De Benedetti F, Insalaco A. Moran-Alvarez P, et al. J Clin Immunol. 2024 Dec 30;45(1):60. doi: 10.1007/s10875-024-01851-1. J Clin Immunol. 2024. PMID: 39738734 No abstract available.